Skip to content
Screener

Maravai LifeSciences Holdings, Inc. MRVI Q3 2025 earnings

Reported November 6, 2025 · After market close

Revenue$41.6MMiss by $7.4M
EPS-$0.08Miss by $0.02
Revenue estimate$49.1M
EPS estimate-$0.06

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$43.7M
EPS estimate-$0.06

Financials

Q3 2025

Income statement

See full
Revenue$41.6M-39.7%
Gross profit$5.7M-82.5%
Operating income-$41.0M+75.2%
Net income-$25.6M+73.7%
EPS (diluted)-$0.18+73.5%

Balance sheet

See full
Cash & equivalents$243.6M-57.9%
Total debt$367.9M-34.4%
Total equity$245.4M-28.8%
Total assets$849.2M-33.6%

Cash flow

See full
Operating cash flow-$15.2M-215%
CapEx$3.7M-57.4%
Free cash flow-$18.8M—

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$415.23M-80.7%
Enterprise value$539.59M-74.7%
P/S2.2×-5.6×

Profitability

See full
Gross margin21.1%-25.2pp
Operating margin-100.9%+57.2pp
Net margin-62.9%-11.6pp
FCF margin-34.5%—

Returns & leverage

See full
Return on equity-41%-7.2pp
Debt / equity1.5×-0.1×
Current ratio5.3×-5.4×

Segments

By geography

See full
Asia Pacific$8.3M-63.6%
Europe, the Middle East and Africa$8.0M-29.9%
Latin and Central America$296.0K+137%

FAQ

When did Maravai LifeSciences Holdings, Inc. report Q3 2025 earnings?
Maravai LifeSciences Holdings, Inc. (MRVI) reported Q3 2025 earnings on November 6, 2025 after market close.
What were Maravai LifeSciences Holdings, Inc.'s Q3 2025 revenue and EPS?
Maravai LifeSciences Holdings, Inc. reported revenue of $41.6M and eps of $-0.08 for Q3 2025.
Did Maravai LifeSciences Holdings, Inc. beat estimates in Q3 2025?
Revenue missed the consensus estimate of $49.1M by $7.4M. EPS missed the consensus estimate of $-0.06 by $0.02.
How did Maravai LifeSciences Holdings, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 36.2% from $65.2M a year earlier and eps declined 300.0% from $-0.02.
Where can I find Maravai LifeSciences Holdings, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001823239-25-000117) and the 10-Q periodic report (0001823239-25-000120) directly on SEC EDGAR. The filing index links above go to sec.gov.